Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors

Paragonix expands board to support rapid commercial growth in the heart transplant market CAMBRIDGE, MASSACHUSETTS, June 22, 2020- Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation…

Continue ReadingParagonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors

Paragonix Technologies Announces Enrollment Milestone for its Global Registry for Donor Heart Preservation

The Paragonix GUARDIAN Registry has reached its 100th patient enrollment milestoneCAMBRIDGE, MASSACHUSETTS, June 2, 2020- Paragonix Technologies, Inc. today announced that its clinical global registry, the Global Utilization And Registry…

Continue ReadingParagonix Technologies Announces Enrollment Milestone for its Global Registry for Donor Heart Preservation

The Donor Heart Guardian – Use of SherpaPak™ CTS at Hospital Clínico, Valladolid, Spain

A group of clinicians transporting a donor heart protected with the Paraognix SherpaPak Cardiac Transport System at Hospital Clínico, Valladolid, Spain Cambridge, Massachusetts — March 17, 2020 – As the…

Continue ReadingThe Donor Heart Guardian – Use of SherpaPak™ CTS at Hospital Clínico, Valladolid, Spain

Paragonix Technologies, Inc., Announces First Successful Use of Paragonix SherpaPak™ Cardiac Transport System in Pediatric Transplant Recipients

  • Post author:
  • Post category:News

Paragonix Technologies, Inc. today announced that the first series of pediatric donor hearts preserved and transported using Paragonix SherpaPak Cardiac Transport System occurred at University of Florida Health (UF Health) and Le Bonheur Children's Hospital (TN). Starting in Q1 2019, Paragonix SherpaPak™ CTS have been shipped with heart connectors covering most aortic diameters, permitting the anchoring of variously sized hearts, including small pediatric hearts, to its proprietary suspension system for improved donor heart transport.

Continue ReadingParagonix Technologies, Inc., Announces First Successful Use of Paragonix SherpaPak™ Cardiac Transport System in Pediatric Transplant Recipients

Paragonix Technologies, Inc. Announces FDA Clearance and U.S. Launch of the Paragonix SherpaPak™ Pancreas Transport System

  • Post author:
  • Post category:News

Paragonix Technologies, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Paragonix SherpaPak™ Pancreas Transport System (PTS). Starting immediately, the Paragonix SherpaPak™ PTS will be commercially available to pancreas transplant centers and Organ Procurement Organizations. The Paragonix SherpaPak PTS provides unprecedented thermal and physical protection to the donor pancreas during transport from donor to recipient patients.

Continue ReadingParagonix Technologies, Inc. Announces FDA Clearance and U.S. Launch of the Paragonix SherpaPak™ Pancreas Transport System

Surgeons at Duke University Hospital Use Advanced Preservation and Transportation System to Safeguard Donor Heart During Journey Between Donor and Recipient

  • Post author:
  • Post category:News

DURHAM, N.C.--(BUSINESS WIRE)-Duke University Hospital has transported its first donor heart using the only commercially available FDA cleared and CE marked system for cold donor heart storage and transport. The…

Continue ReadingSurgeons at Duke University Hospital Use Advanced Preservation and Transportation System to Safeguard Donor Heart During Journey Between Donor and Recipient